Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Jason TardioPresident and COO | ImmunicIMUX | Open-market buyAmendment | 25/06/05 | 25/06/20 | 12,512 sh | $0.79 | $9,884.48 | No record |
Daniel VittCEO and Director | ImmunicIMUX | Open-market buyAmendment | 25/06/04 | 25/06/20 | 15,000 sh | $0.77 | $11,550 | +107.1% |
Duane NashExecutive Chairman | ImmunicIMUX | Open-market buy | 25/06/13 | 25/06/16 | 20,000 sh | $0.83 | $16,600 | +124.8% |
Jason TardioPresident and COO | ImmunicIMUX | Open-market buy | 25/06/05 | 25/06/09 | 12,512 sh | $0.79 | $9,884.48 | No record |
Daniel VittCEO and Director | ImmunicIMUX | Open-market buy | 25/06/04 | 25/06/06 | 15,000 sh | $0.77 | $11,550 | +107.1% |
ImmunicIMUX | Open-market buy | 25/06/04–25/06/05 | 25/06/05 | 100,000 sh2 trades | $0.77avg. | $76,700 | +100.0% | |
Glenn WhaleyCFO | ImmunicIMUX | Open-market buy | 25/06/03 | 25/06/04 | 45,000 sh | $0.71 | $31,950 | +89.1% |
Richard Alan RudickDirector | ImmunicIMUX | Open-market buy | 25/06/03 | 25/06/04 | 143,075 sh | $0.70 | $100,152.5 | +163.9% |
Richard Alan RudickDirector | ImmunicIMUX | Open-market buy | 24/11/12 | 24/11/13 | 87,300 sh | $1.15 | $100,395 | No record |
Daniel VittPresident and CEO | ImmunicIMUX | Open-market buy | 24/02/26 | 24/02/28 | 14,000 sh | $1.31 | $18,340 | +3.7% |
Glenn WhaleyCFO | ImmunicIMUX | Open-market buy | 23/05/15 | 23/05/16 | 5,000 sh | $1.75 | $8,750 | +24.4% |